| NCT Number | NCT07254208 |
| Lead Sponsor | Precision BioSciences, Inc. |
| Conditions | Chronic HBV Infection |
| Enrollment | 45 participants |
| Start Date | 2025-12-25 |
| Primary Completion | 2040-01 (estimated) |
| Study Completion | 2040-06 (estimated) |
| Updated on ClinicalTrials.gov | 2026-04-22 |